Sukumar Sakamuri, PhD

Chief Technology Officer at Aro Biotherapeutics

Sukumar Sakamuri is currently working as Chief Technology Officer at Aro Biotherapeutics, Philadelphia, USA. He has over 20 years of drug discovery experience in biotech industry and proven entrepreneurial leadership, co-founding a biotech company Tollnine. He is an expert in developing novel drug discovery technology platforms including oligonucleotides, antibody drug conjugates, peptides and small molecules. Prior to joining Aro, Dr. Sakamuri has worked in increasing responsibilities at Ambrx, Tollnine, Solstice, Traversa and CovX. He has advanced multiple programs in immuno-oncology, oncology, rare and genetic diseases, metabolic and diabetes indications into preclinical and clinical development. Dr. Sakamuri is an inventor and author of over 45 patents, patent applications and publications. He conducted postdoctoral research in medicinal chemistry at Georgetown University, Washington, DC and holds a Ph.D. in organic chemistry from the Indian Institute of Chemical Technology, India.